Developer Tools & Infrastructure
1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
- Therapeutics
- AI-powered Drug Discovery
- Website
- 1910.ai
- Headquarters
- Boston, MA, USA
- Team size
- 11-50 people
- Founded
- 2019
- Demo
- Demo only
Similar companies
KeylikaRedefining the Standard of Care for Iron Deficiency Anemia
Evolvere BioSciencesMaking Next-Generation Antibiotics that Outpace Bacterial Evolution
WonderTxExtrapolative AI to unlock First-in-Class drugs
Exin TherapeuticsAI drug discovery platform for neurotherapeutics
Promakhos TherapeuticsA therapeutics platform for curing inflammatory disorders
Relevium MedicalPlatform injectable gel based therapeutic for osteoarthritis
Humane GenomicsA platform to make artificial viruses as cancer therapeutics.
Synkrino BiotherapeuticsSynkrino's AI, SATIS is a powerful, unbiased discovery system for…